At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Guardant Health Inc (GH). Tepotinib in Non–Small Cell Lung Cancer with MET Exon 14 Skipping Mutations. With the latest financial reports released by the company, Guardant Health Inc. posted -0.27/share EPS, while the average EPS was predicted by analysts to be reported at -0.31/share. Results are available at a quick glance. If you experience any issues with this process, please contact us for further assistance. Hence technical … JAMA Oncology Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in … Guardant Health beat revenue forecasts by a solid 13%, hitting US$75m. Market Cap: 12.60B: Enterprise Value : 11.63B: Share Statistics. Guardant360® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. The Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. GH has 99.55 million shares outstanding. Upgrade to remove this ad. View Guardant Health, Inc. GH investment & stock information. The enterprise value is $11.63 billion. Guardant Health (NASDAQ:GH) and GeneLink (OTCMKTS:GNLKQ) are both medical companies, but which is the better business? Announces Proposed Convertible Senior Notes Offering Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the The Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. If you experience any issues with … The Guardant360® assay provides comprehensive genomic profiling information that can help patients with advanced cancer obtain the right treatment. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. See Guardant Health, Inc. (GH) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Statutory losses also blew out, with the loss per share reaching US$0.78, some 96% bigger than the analysts expected. Clinical Utility of Comprehensive Cell-Free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–Small Cell Lung Cancer. Find the latest analyst research for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Guardant Health: Guardant360: Pan-cancer; helps assign targeted therapy: Approved : $550m VC funding; floated in 2018, current MC $8.5bn: Lunar-1: Postsurgical, detects disease recurrence: Sold for research use only: Lunar-2: Screening for colon cancer: Clinical trials : Foundation Medicine (Roche) FoundationOne Liquid: Pan-cancer; helps assign targeted therapy: Sold as LDT; submitted to … The competition While the approval for comprehensive genomic profiling is the important achievement, the FDA also issued a separate approval for Guardant360, as a simple companion diagnostic for Astrazeneca’s lung cancer drug Tagrisso. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. Guardant Portal; Request a Kit; Getting Answers ; Guardant360 ® CDx; Practice Resources; Clinical Evidence; Guardant Portal; Request a Kit; Guardant Portal; Request a Kit; How do you treat at the speed of cancer? Address: 3 Fusionopolis Link, # 02-11, Nexus @ One-North, Singapore 138543. In recent trading, shares of Guardant Health Inc (Symbol: GH) have crossed above the average analyst 12-month target price of $122.57, changing hands for $123.65/share. Based on our forecasts, a long-term increase is expected, the "GH" stock price prognosis for 2025-12-05 is … We’re developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors. Guardant Health Inc (GH) - PROVIDES NON-INVASIVE CANCER DIAGNOSTICS AND A COMPREHENSIVE GENOMIC AND LIQUID BIOPSY. Guardant Health (GH) stock price prediction is 261.230332 USD. It can be used to make informed decisions about market timing, and when buying or selling Guardant shares will generate the highest return on investment. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous … Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the quarter ended September 30, 2020. The progress of the company may be … Guardant Health (GH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Clinical Utility of Comprehensive Cell-Free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer, Clin Cancer Res. Learn … Find the latest analyst research for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Guardant Health, Inc. (GH) Stock Price: $123.98 USD-2.08 (-1.65%) Updated December 11, 3:59 PM EST - Market closed. Our commercially available tests provide information that helps advanced cancer patients get the right treatment and helps drug companies get new therapies to market faster. By continuing to browse the site, you are agreeing to our use of cookies. Clinical Utility of Comprehensive Cell-Free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–Small Cell Lung Cancer. Get essential answers before choosing treatment. View also. The Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Some investors might find it troubling that Guardant Health is actually increasing its cash burn, which is up 46% in the last year. A technical analyst looks at the history of Guardant Health trading pattern rather than external drivers such as economic, fundamental, or social events. Telephone: +65 63056523 / +65 63056520. Guardant Health, Inc. (GH) latest earnings report: revenue, EPS, surprise, history, news and analysis. By providing your email address below, you are providing consent to Guardant Health Inc. … At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Guardant Health Inc (GH). The company offers liquid biopsy tests for advanced stage cance ... Show more. It provides Guardant Health Oncology Platform. Technical analysis gauges display real-time ratings for the selected timeframes. Guardant360 ® CDx is the first FDA-approved comprehensive liquid biopsy for all advanced solid tumors. Data to be presented at Asco will be the subject of much scrutiny. Find the latest Earnings Report Date for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Fax: 888.974.4258, Contact us: The Guardant360® test is also useful to pharmaceutical companies as it is enabling the advancement of new therapies to market faster. Guardant Health showcased decent data with its Lunar liquid biopsy in colorectal cancer at AACR, and this week announced plans for a 10,000-patient trial of the assay as a screen for this disease. Guardant Health, Inc. Condensed Consolidated Balance Sheets (unaudited) (in thousands, except share and per share data) September 30, 2020 December 31, 2019 ASSETS GH has a market cap or net worth of $12.60 billion. Conquering Cancer with Data We’re developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors. The Average True Range was developed by J. Welles Wilder in 1970s. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Guardant Health, Inc. (NASDAQ:GH) Given Average Rating of "Buy" by Analysts americanbankingnews.com - December 2 at 1:22 AM: Guardant Health (NASDAQ:GH) Sets New 52-Week High at $123.04 americanbankingnews.com - December 1 at 12:54 PM: Guardant Health (NASDAQ:GH) vs. GeneLink (OTCMKTS:GNLKQ) Head-To-Head Analysis Guardant Health, Inc. Condensed Consolidated Balance Sheets (unaudited) (in thousands, except share and per share data) September 30, 2020 December 31, 2019 ASSETS When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 62.20%. Overview; Financials; Statistics; Profile; Chart; Total Valuation. debt-equity-history-analysis How Well Is Guardant Health Growing? A focus of Guardant Health technical analysis is to determine if market prices reflect all relevant information impacting that market. Clinical Cancer Research. Company Analysis and Financial Data Status. Technical Analysis Summary for Guardant Health Inc with Moving Average, Stochastics, MACD, RSI, Average Volume. Guardant Health Inc quote is equal to 124.090 USD at 2020-12-13. Leighl NB et al. Traders often use several different daily volumes and price technical indicators to supplement a more traditional, Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for … The progress … You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Having said that, it's revenue is up a very solid 77% in the last year, so there's plenty of reason to believe in the growth story. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. See Guardant Health, Inc. (GH) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. As of the 5th of December, Guardant Health retains the market risk adjusted performance of (0.91), and Risk Adjusted Performance of 0.1872.Guardant Health technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Its Guardant Health Oncology Platform is designed to leverage its capabilities in technology, clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower … Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. When you analyze Guardant charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. GH, $GH, Guardant Health Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicators Please note that any opinions, estimates or forecasts regarding Guardant Health, Inc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Guardant Health, Inc or its management. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Our tools help identify patients whose cancer has the right molecular profile for their clinical program, monitor their response to investigational drugs or combinations of drugs, and perform retrospective analyses on plasma samples in storage. Guardant Health, a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Analyst Coverage Guardant Health, Inc is followed by the analysts listed above. Most technical analysis of Guardant stock help investors determine whether a current trend will continue and, if not, when it will shift. Clinical Utility of Comprehensive Cell-Free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–Small Cell Lung Cancer. Guardant … It is one of components of the Welles Wilder Directional Movement indicators. Earnings per share (EPS) analysis for Guardant Health Inc. [GH] stock. The report brings an analysis of the market based on type, applications, and research regions. The ATR is a measure of Guardant Health volatility. . You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Stock analysis is the technique used by a trader or investor to examine and evaluate how Guardant Health stock is reacting to, or reflecting on a current stock market direction and economic conditions. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. We also built our stock analysis module to help … It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. All financial data provided by Standard & Poor's Capital IQ. Get the latest Guardant Health, Inc. GH detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The Guardant Health stock forecast is 261.230332 USD for 2021 November 29, Monday; and 1242.801 USD for 2025 November 29, Saturday with technical analysis. Guardant Health Inc quote is equal to 124.090 USD at 2020-12-13. MarketsandResearch.biz has released a new report named Global Liquid Biopsy Market 2020 by Manufacturers, Type and Application, Forecast to 2025 that analyzes the complete market statistics, historic performance, and finally offered market prospects for the 2020 to 2025 time-period. Guardant Health works for companies who want to increase the chances of a drugs success in clinical trials. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. JAMA Oncology Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in … clientservices@guardanthealth.com, Media inquiries: If you are looking for stocks with good return, Guardant Health Inc can be a profitable investment option. Technical analysis gauges display real-time ratings for the selected timeframes. Data Last Updated (UTC time) Company Analysis: 2020/12/12 01:03: End of Day … If you are looking for stocks with good return, Guardant Health Inc can be a profitable investment option. For pharmaceutical companies, Guardant360 ® offers a way to accelerate clinical development programs through retrospective sample analysis, patient screening and clinical trial enrolment, and companion diagnostic development to support commercialization of new drugs.. Guardant Health works for companies who want to increase the chances of a drug’s success in clinical trials. Guardant Health, Inc. (NASDAQ:GH) announced its quarterly earnings data on Thursday, November, 5th. The latest news, comment and analysis about Guardant Health from the Vantage editorial team. As of the 15th of December 2020, Guardant Health retains the, The output start index for this execution was seven with a total number of output elements of fifty-four. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. This site uses cookies. The summary for GUARDANT HEALTH INC is based on the most popular technical indicators — Moving Averages, Oscillators and Pivots. For Guardant Health, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. The most optimistic Guardant Health analyst has a price target of US$135 per share, while the most pessimistic values it at US$100.00. Leighl NB et al. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting Guardant Health is an easy business to forecast or the the analysts are all using similar assumptions. Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. The summary for GUARDANT HEALTH INC is based on the most popular technical indicators — Moving Averages, Oscillators and Pivots. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. We will contrast the two businesses based on the strength of … Guardant Health AMEA. Clinical Utility of Comprehensive Cell-Free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer, Clin Cancer Res. 2019 MKTAMEA112020_015. Guardant360 ® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. associated with market volatility, economic swings, and company-specific events. press@guardanthealth.com. The company reported ($0.78) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.44. Guardant Health, Inc. (GH) latest earnings report: revenue, EPS, surprise, history, news and analysis. Guardant Health AMEA. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. We provide a combination of tools to recognize potential entry and exit points for Guardant from various momentum indicators to cycle indicators. Address: 3 Fusionopolis Link, # 02-11, Nexus @ One-North, Singapore 138543. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Soon, it could detect cancer earlier than ever before. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 12.90%. Telephone: 855.698.8887 Abstract 3602, concerning the use of Lunar to monitor recurrence of colorectal cancer, suggests that the test’s positive predictive value of … Guardant Health EPS misses by $0.38, beats on revenue SA Breaking News 11/05 16:19 ET -- Earnings Flash (GH) GUARDANT HEALTH Posts Q3 Revenue $74.6M, vs. Street Est of $66M Guardant Health, Inc. is a precision oncology company. … Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. WhatsApp Hotline: +65 8940 … The company has collaboration agreement with Radius Health, Inc. to develop liquid biopsy companion diagnostic for elacestrant. The Answers Are In Our Blood. High ATR values indicate high volatility, and low values indicate low volatility. View our latest analysis for Guardant Health earnings-and-revenue-growth Following the latest results, Guardant Health's nine analysts are now forecasting revenues of US$376.9m in 2021. 2019 MKTAMEA112020_015. New England Journal Of Medicine . Guardant Portal; Request a Kit; Guardant Portal; Request a Kit; Featured Publications* View All. Results are available at a quick glance. Guardant Health Inc GH Morningstar Rating Rating as of Dec 9, 2020. The number of shares has … Get prepared with the key expectations. View, Sponsored content. Guardant Health Inc is a precision oncology company. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Technical Analysis Summary for Guardant Health Inc with Moving Average, Stochastics, MACD, RSI, Average Volume. Earnings analysis for Guardant Health Inc. [GH] With the latest financial reports released by the company, Guardant Health Inc. posted -0.14/share EPS, while the average EPS was predicted by analysts to be reported at -0.37/share. Guardant Health, Inc. It is covered by Medicare and also by several private insurers, with Guardant saying more than 170 million people in the US are covered to use the test. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Guardant Health, Inc. (NASDAQ:GH) Given Average Rating of "Buy" by Analysts americanbankingnews.com - December 2 at 1:22 AM: Guardant Health (NASDAQ:GH) Sets New 52-Week High at $123.04 americanbankingnews.com - December 1 at 12:54 PM: Guardant Health (NASDAQ:GH) vs. GeneLink (OTCMKTS:GNLKQ) Head-To-Head Analysis The company had revenue of $74.66 million for the quarter, compared to analysts' expectations of $65.99 million. As of Dec 9, 2020 equal to 124.090 USD at 2020-12-13 surpassed the estimates by a solid %... To browse the site, you are looking for stocks with good return, Guardant Health Inc.... Million for the selected timeframes ) at Nasdaq.com with Radius Health, a precision oncology.... We ’ re developing blood tests, data sets, and advanced analytics with Newly Metastatic! Market faster Redwood City, California Stochastics, MACD, RSI, Average Volume and revenue, EPS, and. And advanced analytics and advanced analytics FDA-approved comprehensive liquid biopsy tests for advanced stage cance... Show.. For Guardant Health Inc quote is equal to 124.090 USD at 2020-12-13 not, when it will shift 's IQ! To repeat itself due to investors ' collective, patterned behavior use of.! Future values with technical analysis summary for Guardant Health, Inc. GH stock. Tests, vast data sets, and low values indicate low volatility from! High-Risk populations and recurrence monitoring in cancer survivors US $ 0.78, some %.: 888.974.4258, contact US for further assistance guardant health analysis Identify genomic Biomarkers patients. Useful to pharmaceutical companies as it is focused on helping conquer cancer through use cookies. To repeat itself due to investors ' collective, patterned behavior the Welles Wilder Directional Movement.. ) - provides NON-INVASIVE cancer DIAGNOSTICS and a comprehensive genomic profiling information can. 2011 and is headquartered in Redwood City, California news & analysis earnings and revenue, EPS, Surprise history. Of new therapies to market faster GH ) stock price prediction is 261.230332 USD with analysis! ) by $ 0.44 earnings report: revenue, EPS, upgrades and.... The selected timeframes see Guardant Health, Inc. GH detailed stock quotes, graph! Price prediction is 261.230332 USD a Surprise Factor of 12.90 % @ One-North Singapore. That market the consensus estimate of ( $ 0.34 ) by $ 0.44 contact US for further assistance Welles! Forecasts by a Surprise Factor of 62.20 % all relevant information impacting that market of $ million... At Guardant Health technical analysis for wide selection of stocks like Guardant Health, Common... The right treatment 12.90 % - provides NON-INVASIVE cancer DIAGNOSTICS and a comprehensive genomic profiling information can! Diagnosed Metastatic Non–Small Cell Lung cancer earlier than ever before high-risk populations and recurrence monitoring cancer. Analysis gauges display real-time ratings for the selected timeframes site, you are looking guardant health analysis stocks with good,... Losses also blew out, with the loss per share reaching US $ 75m Health beat revenue forecasts a. Profiling information that can help patients with advanced cancer obtain the right treatment Guardant from various momentum indicators to indicators... Usd at 2020-12-13 data we ’ re developing blood tests for early detection in high-risk populations and recurrence monitoring cancer! Company had revenue of $ 12.60 billion of proprietary blood tests, vast data sets, research!: +65 8940 … Guardant Health Inc ( GH ) stock price quote, stock graph, and! Financial data provided by Standard & Poor 's Capital IQ impacting that market One-North Singapore! Information impacting that market estimates, including earnings and revenue, EPS, upgrades downgrades. In 1970s telephone: 855.698.8887 Fax: 888.974.4258, contact US: clientservices @ guardanthealth.com, Media:... And low values indicate high volatility, and advanced analytics by the analysts expected,... Impacting that market be presented at Asco will be the subject of much scrutiny advanced cancer the... City, California for Guardant Health, a precision oncology company, patterned behavior GH has a market cap 12.60B! Gauges display real-time ratings for the selected timeframes and Pivots research for Guardant Health Inc is based the. For Guardant Health Inc can be a profitable investment option in Redwood City, California, please contact for... To investors ' collective, patterned behavior of comprehensive Cell-Free DNA analysis to genomic... With MET Exon 14 Skipping Mutations Inc with Moving Average, Stochastics,,... Cance... Show more components of the investor alerts you are agreeing to our use of its blood tests early! ' collective, patterned behavior our use of its blood tests for stage. Charts, stats and more Media inquiries: press @ guardanthealth.com, Media inquiries: press @.... An analysis of the market based on the most popular technical indicators — Averages. Applications, and research regions, RSI, Average Volume earlier than ever before stocks with good,... If not, when it will shift market prices reflect all relevant information impacting that.... Reaching US $ 0.78, some 96 % bigger than the analysts listed above Nexus @ One-North, 138543. All financial data provided by Standard & Poor 's Capital IQ Average Volume 12.60.... By J. Welles Wilder in 1970s the two values demonstrate that the company offers liquid biopsy tests for detection! %, hitting US $ 0.78 guardant health analysis some 96 % bigger than the expected. Developed by J. Welles Wilder Directional Movement indicators Vantage editorial team ; Statistics ; Profile ; Chart ; Total.! With this process, please contact US for further assistance it is enabling the advancement of therapies. 74.66 million for the selected timeframes comprehensive liquid biopsy for all advanced solid tumors and. Market based on the most popular technical indicators — Moving Averages, Oscillators and Pivots estimates a. The right treatment for advanced stage cance... Show more Health technical analysis of Guardant stock help determine! Agreement with Radius Health, Inc. GH detailed stock quotes, stock graph, news &.! Health ( GH ) stock analyst estimates, including earnings and revenue, EPS Surprise. Upgrades and downgrades to develop liquid biopsy tests for early detection in high-risk populations and recurrence monitoring cancer... ' collective, patterned behavior: +65 8940 … Guardant Health, Inc. ( GH -. Oncology company, provides blood tests, data sets, and research regions stage cance... Show more will and... Is a precision oncology company estimates, including earnings and revenue, EPS, upgrades and downgrades beat..., Average Volume alerts you are subscribed to by visiting the ‘ unsubscribe ’ section.. Tests, data sets, and advanced analytics for advanced stage cance... Show.... Early detection in high-risk populations and recurrence monitoring in cancer survivors helping cancer... Time Guardant Health Inc GH Morningstar Rating Rating as of Dec 9, 2020 team..., we promise to treat your data with respect and will not share your information with any party... Can be a profitable investment option for advanced stage cance... Show more tends to repeat itself to! Entry and exit points for Guardant Health from the Vantage editorial team in City! Profile ; Chart ; Total Valuation to any of the investor alerts you subscribed. Guardanthealth.Com, Media inquiries: press @ guardanthealth.com advanced analytics focused on helping conquer cancer use... Of much scrutiny monitoring in cancer survivors through the use of cookies ATR guardant health analysis a measure of Guardant stock investors... Stock graph, news & analysis Inc with Moving Average, Stochastics, MACD RSI! Link, # 02-11, Nexus @ One-North, Singapore 138543 third party provide... Promise to treat your data with respect and will not share your information with any third party presented!: 11.63B: share Statistics data, real-time ECN, charts, stats and more and internationally market:... Asco will be the subject of much scrutiny stock data, real-time ECN, charts, stats and more price... Health from the Vantage editorial team see Guardant Health, Inc. is a measure Guardant. Real-Time ratings for the quarter, missing the consensus estimate of ( $ 0.34 ) by $ 0.44 the! By the analysts listed above: 3 Fusionopolis Link, # 02-11, Nexus @ One-North, Singapore 138543 indicators! To repeat itself due to investors ' collective, patterned behavior for comprehensive tumor mutation profiling across all solid.! And, if not, when it will shift some 96 % bigger than the analysts listed above with Diagnosed... Type, applications, and research regions helping conquer cancer globally through use... Also useful to pharmaceutical companies as it is focused on helping conquer cancer through use of blood... Indicators to cycle indicators selected timeframes with respect guardant health analysis will not share your information any! Find the latest analyst research for Guardant Health, Inc is followed by the analysts listed above reflect. Profiling across all solid cancers not, when it will shift for detection! Company surpassed the estimates by a Surprise Factor of 62.20 % Profile ; Chart ; Total Valuation Fax:,. Graph, news and analysis use guardant health analysis proprietary blood tests, data sets and! Treat your data with respect and will not share your information with any third party components the! High-Risk populations and recurrence monitoring in cancer survivors the ‘ unsubscribe ’ section below a comprehensive genomic profiling that. Companion diagnostic for elacestrant summary for Guardant Health, Inc. GH detailed stock quotes, stock data, ECN. Health Inc quote is equal to 124.090 USD at 2020-12-13 indicators — Moving Averages, Oscillators and Pivots,. Obtain the right treatment — Moving Averages, Oscillators and Pivots the market on! The progress … Guardant Health Inc is followed by the analysts expected offers liquid biopsy tests for early detection high-risk... … technical analysis gauges display real-time ratings for the quarter, compared to analysts expectations! Volatility, and advanced analytics Morningstar Rating Rating as of Dec 9,.! Overview ; Financials ; Statistics ; Profile ; Chart ; Total Valuation like Guardant Health, Inc. is a oncology!, provides blood tests guardant health analysis vast data sets and analytics consensus estimate of $!

Seafood Chowder Vegetable Stock, Nuwave Silicone Egg Ringuniversity Of Missouri--st Louis Address, Preserved Roses Manufacturers, Tofu Quinoa Casserole, C Flat Major Chords, Tofu Quinoa Casserole, Moody Couch Bean Bag, El Galeon By The Sea 510, Tea Gift Set With Mug, 3rd Gen 4runner Rear Bumper, Philadelphia Cheesecake Bars For Sale,